{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:28:14Z","timestamp":1791282494935,"version":"4.1.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10585-015-9750-1","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T07:52:08Z","timestamp":1443513128000},"page":"857-866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases"],"prefix":"10.1007","volume":"32","author":[{"given":"Kasoha","family":"Mariz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhasz-B\u00f6ss","family":"Ingolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herr","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ney Jasmin","family":"Teresa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomayer","family":"Erich-Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"issue":"12","key":"9750_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893\u20132917","journal-title":"Int J Cancer"},{"key":"9750_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","volume":"10","author":"W Kozlow","year":"2005","unstructured":"Kozlow W, Guise TA (2005) Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 10:169\u2013180","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"9750_CR3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584\u2013593","journal-title":"Nat Rev Cancer"},{"key":"9750_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11864-005-0023-0","volume":"6","author":"A Lipton","year":"2005","unstructured":"Lipton A (2005) Management of bone metastases in breast cancer. Cur Treat Options Oncol 6:161\u2013171","journal-title":"Cur Treat Options Oncol"},{"key":"9750_CR5","doi-asserted-by":"crossref","unstructured":"Aubin JE, Triffitt J (2002) Mesenchymal stem cells and the osteoblast lineage. In: Principles of bone biology, 2nd edn. Academic Press, New York, pp 59\u201381","DOI":"10.1016\/B978-012098652-1.50106-2"},{"key":"9750_CR6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","volume":"20","author":"T Suda","year":"1999","unstructured":"Suda T, Takahashi N, Udagawa N et al (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345\u2013357","journal-title":"Endocr Rev"},{"key":"9750_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"9750_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modelling and remodelling. Arch Biochem Biophys 473:139\u2013146","journal-title":"Arch Biochem Biophys"},{"key":"9750_CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mce.2008.11.002","volume":"310","author":"JM Quinn","year":"2009","unstructured":"Quinn JM, Saleh H (2009) Modulation of osteoclast function in bone by the immune system. Mol Cell Endocrinol 310:40\u201351","journal-title":"Mol Cell Endocrinol"},{"key":"9750_CR10","author":"MN Weitzmann","year":"2013","unstructured":"Weitzmann MN (2013) The role of inflammatory cytokines, the RANKL\/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. Scientifica. doi: 10.1155\/2013\/125705","journal-title":"Scientifica"},{"key":"9750_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ (2003) The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer 3:1\u20136","journal-title":"Nat Rev Cancer"},{"key":"9750_CR12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang J, Mani SA, Donaher JL et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastases. Cell 117:927\u2013939","journal-title":"Cell"},{"key":"9750_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.1.3.1","volume":"3","author":"BL Eckhardt","year":"2005","unstructured":"Eckhardt BL, Parker BS, van Laar RK et al (2005) Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol Cancer Res 3:1\u201313","journal-title":"Mol Cancer Res"},{"key":"9750_CR14","first-page":"139","volume":"3","author":"OL Bohn","year":"2009","unstructured":"Bohn OL, Nasir I, Brufsky A et al (2009) Biomarker profile in breast carcinomas presenting with bone metastasis. Int J Clin Exp Pathol 3:139\u2013146","journal-title":"Int J Clin Exp Pathol"},{"key":"9750_CR15","first-page":"955","volume":"38","author":"D Ota","year":"2011","unstructured":"Ota D, Mimori K, Yokobori T et al (2011) Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. Int J Oncol 38:955\u2013962","journal-title":"Int J Oncol"},{"key":"9750_CR16","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","volume":"68","author":"LR Patel","year":"2008","unstructured":"Patel LR, Camacho DF, Shiozawa Y et al (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68:3645\u20133654","journal-title":"Cancer Res"},{"key":"9750_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","volume":"10","author":"TT Onder","year":"2005","unstructured":"Onder TT, Gupta PB, Mani SA et al (2005) Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. Mammary Gland Biol Neoplasia 10:169\u2013180","journal-title":"Mammary Gland Biol Neoplasia"},{"key":"9750_CR18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3816\/CBC.2005.s.004","volume":"5","author":"TA Guise","year":"2005","unstructured":"Guise TA, Kozlow WM, Heras-Herzig A et al (2005) Molecular mechanisms of breast cancer metastases to bone. Clin Breast Cancer 5:46\u201353","journal-title":"Clin Breast Cancer"},{"key":"9750_CR19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11132","volume":"97","author":"SM Kakonen","year":"2003","unstructured":"Kakonen SM, Mundy GR (2003) Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer 97:834\u2013839","journal-title":"Cancer"},{"key":"9750_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","volume":"10","author":"W Kozlow","year":"2005","unstructured":"Kozlow W, Guise TA (2005) Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. Mammary Gland Biol Neoplasia 10:169\u2013180","journal-title":"Mammary Gland Biol Neoplasia"},{"key":"9750_CR21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ccr.2010.12.022","volume":"19","author":"N Sethi","year":"2011","unstructured":"Sethi N, Dai X, Winter CG, Kang Y (2011) Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 19:192\u2013205","journal-title":"Cancer Cell"},{"key":"9750_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1026526703898","volume":"1","author":"A Karaplis","year":"2000","unstructured":"Karaplis A, Goltzman D (2000) PTH and PTHrP effects on the skeleton. Rev Endocr Metab Disord 1:331\u2013341","journal-title":"Rev Endocr Metab Disord"},{"key":"9750_CR23","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1172\/JCI46134","volume":"121","author":"J Li","year":"2011","unstructured":"Li J, Karaplis AC, Huang DC et al (2011) PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target. J Clin Investig 121:4655\u20134669","journal-title":"J Clin Investig"},{"key":"9750_CR24","first-page":"139","volume":"3","author":"OL Bohn","year":"2010","unstructured":"Bohn OL, Nasir I, Brufsky A et al (2010) Biomarker profile in breast carcinomas presenting with bone metastasis. Int J Clin Exp Pathol 3:139\u2013146","journal-title":"Int J Clin Exp Pathol"},{"key":"9750_CR25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise TA, Yin JJ, Taylor SD et al (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Investig 98:1544\u20131549","journal-title":"J Clin Investig"},{"key":"9750_CR26","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1172\/JCI117990","volume":"95","author":"J Mata de la","year":"1995","unstructured":"de la Mata J, Uy HL, Guise TA et al (1995) Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Investig 95:2846\u20132852","journal-title":"J Clin Investig"},{"key":"9750_CR27","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","volume":"65","author":"MS Bendre","year":"2005","unstructured":"Bendre MS, Margulies AG, Walser B et al (2005) Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res 65:11001\u201311009","journal-title":"Cancer Res"},{"key":"9750_CR28","doi-asserted-by":"crossref","first-page":"21352","DOI":"10.1074\/jbc.M111663200","volume":"277","author":"SL Dallas","year":"2002","unstructured":"Dallas SL, Rosser JL, Mundy GR et al (2002) Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 277:21352\u201321360","journal-title":"J Biol Chem"},{"key":"9750_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537\u2013549","journal-title":"Cancer Cell"},{"key":"9750_CR30","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1359\/JBMR.050802","volume":"20","author":"BT Feeley","year":"2005","unstructured":"Feeley BT, Gamradt SC, Hsu WK et al (2005) Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J Bone Miner Res 20:2189\u20132199","journal-title":"J Bone Miner Res"},{"key":"9750_CR31","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1158\/0008-5472.CAN-05-1891","volume":"65","author":"J Dai","year":"2005","unstructured":"Dai J, Keller J, Zhang J et al (2005) Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res 65:8274\u20138285","journal-title":"Cancer Res"},{"key":"9750_CR32","author":"LS Gregory","year":"2013","unstructured":"Gregory LS, Choi W, Burke L et al (2013) Breast cancer cells induce osteolytic bone lesions in vivo through a reduction in osteoblast activity in mice. PLoS One. doi: 10.1371\/journal.pone.0068103","journal-title":"PLoS One"},{"key":"9750_CR33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2009.06.002","volume":"310","author":"F Milat","year":"2009","unstructured":"Milat F, Ng KW (2009) Is Wnt signalling the final common pathway leading to bone formation? Mol Cell Endocrinol 310:52\u201362","journal-title":"Mol Cell Endocrinol"},{"key":"9750_CR34","doi-asserted-by":"crossref","first-page":"22429","DOI":"10.1074\/jbc.R600015200","volume":"281","author":"MD Gordon","year":"2006","unstructured":"Gordon MD, Nusse R (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429\u201322433","journal-title":"J Biol Chem"},{"key":"9750_CR35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1242\/jcs.02826","volume":"119","author":"KM Cadigan","year":"2006","unstructured":"Cadigan KM, Liu YI (2006) Wnt signalling: complexity at the surface. J Cell Sci 119:395\u2013402","journal-title":"J Cell Sci"},{"key":"9750_CR36","first-page":"3001.1","volume":"3","author":"JR Miller","year":"2002","unstructured":"Miller JR (2002) The Wnts. Genome Biol 3:3001.1\u20133001.15","journal-title":"Genome Biol"},{"key":"9750_CR37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers H (2006) Wnt\/\u03b2-Catenin signaling in development and disease. Cell 127:469\u2013480","journal-title":"Cell"},{"key":"9750_CR38","author":"R Amerongen van","year":"2008","unstructured":"van Amerongen R, Mikels A, Nusse R (2008) Alternative Wnt signaling is initiated by distinct receptors. Sci Signal. doi: 10.1126\/scisignal.135re9","journal-title":"Sci Signal"},{"key":"9750_CR39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1091\/mbc.E08-07-0711","volume":"20","author":"V Bryja","year":"2009","unstructured":"Bryja V, Andersson ER, Shambony A et al (2009) The extracellular domain of Lrp5\/6 inhibits noncanonical Wnt signaling in vivo. Mol Biol Cell 20:924\u2013936","journal-title":"Mol Biol Cell"},{"key":"9750_CR40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1242\/jcs.026096","volume":"121","author":"P Bovolenta","year":"2008","unstructured":"Bovolenta P, Esteve P, Ruiz JM et al (2008) Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci 121:737\u2013746","journal-title":"J Cell Sci"},{"key":"9750_CR41","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1242\/dev.01117","volume":"131","author":"X He","year":"2004","unstructured":"He X, Semenov M, Tamai K et al (2004) LDL receptor-related proteins 5 and 6 in Wnt\/\u03b2-catenin signaling: arrows point the way. Development 131:1663\u20131677","journal-title":"Development"},{"key":"9750_CR42","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Investig 116:1202\u20131209","journal-title":"J Clin Investig"},{"key":"9750_CR43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jcb.22020","volume":"106","author":"C Yan","year":"2009","unstructured":"Yan C, Benjamin A (2009) Wnt pathway, an essential role in bone regeneration. J Cell Biochem 106:353\u2013362","journal-title":"J Cell Biochem"},{"key":"9750_CR44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.devcel.2005.02.013","volume":"8","author":"TP Hill","year":"2005","unstructured":"Hill TP, Sp\u00e4ter D, Taketo MM et al (2005) Canonical Wnt\/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727\u2013738","journal-title":"Dev Cell"},{"key":"9750_CR45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bone.2005.02.001","volume":"36","author":"BLT Vaes","year":"2005","unstructured":"Vaes BLT, Dechering KJ, van Someren EP et al (2005) Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts. Bone 36:803\u2013811","journal-title":"Bone"},{"key":"9750_CR46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1083\/jcb.200201089","volume":"157","author":"M Kato","year":"2002","unstructured":"Kato M, Patel MS, Levasseur R et al (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303\u2013314","journal-title":"J Cell Biol"},{"key":"9750_CR47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass 2nd","year":"2005","unstructured":"Glass DA 2nd, Bialek P, Ahn JD et al (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751\u2013764","journal-title":"Dev Cell"},{"key":"9750_CR48","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1634\/stemcells.2005-0220","volume":"24","author":"WG Gunn","year":"2006","unstructured":"Gunn WG, Conley A, Deininger L et al (2006) A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells 24:986\u2013991","journal-title":"Stem Cells"},{"key":"9750_CR49","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/pros.20805","volume":"68","author":"CL Hall","year":"2008","unstructured":"Hall CL, Daignault SD, Shah RB et al (2008) Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis. Prostate 68:1396\u20131404","journal-title":"Prostate"},{"key":"9750_CR50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0955-0674(97)80122-6","volume":"9","author":"AL Barth","year":"1997","unstructured":"Barth AL, N\u00e4thke IS, Nelson WJ (1997) Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 9:683\u2013690","journal-title":"Curr Opin Cell Biol"},{"key":"9750_CR51","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2009.05.002","volume":"137","author":"E Fuchs","year":"2009","unstructured":"Fuchs E (2009) The tortoise and the hair: slow-cycling cells in the stem cell race. Cell 137:811\u2013819","journal-title":"Cell"},{"key":"9750_CR52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/B:JOMG.0000037157.94207.33","volume":"9","author":"KR Brennan","year":"2004","unstructured":"Brennan KR, Brown AMC (2004) Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia 9:119\u2013131","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"9750_CR53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1025944723047","volume":"8","author":"S Hatsell","year":"2003","unstructured":"Hatsell S, Rowlands T, Hiremath M et al (2003) Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8:145\u2013158","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"9750_CR54","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(87)90038-9","volume":"14","author":"F Rijsewijk","year":"1987","unstructured":"Rijsewijk F, Schuermann M, Wagenaar E et al (1987) The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 14:649\u2013657","journal-title":"Cell"},{"key":"9750_CR55","author":"JR Prosperi","year":"2011","unstructured":"Prosperi JR, Khramtsov AI, Khramtsova GF et al (2011) Apc mutation enhances PyMT-induced mammary tumorigenesis. PLOS One. doi: 10.1371\/journal.pone.0029339","journal-title":"PLOS One"},{"key":"9750_CR56","first-page":"641","volume":"25","author":"E Klopocki","year":"2004","unstructured":"Klopocki E, Kristiansen G, Wild PJ et al (2004) Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol 25:641\u2013649","journal-title":"Int J Oncol"},{"key":"9750_CR57","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/carcin\/bgi379","volume":"27","author":"L Ai","year":"2006","unstructured":"Ai L, Tao Q, Zhong S et al (2006) Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis 27:1341\u20131348","journal-title":"Carcinogenesis"},{"key":"9750_CR58","first-page":"385","volume":"24","author":"SJ Zardawi","year":"2009","unstructured":"Zardawi SJ, O\u2019Toole SA, Sutherland RL et al (2009) Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol Histopathol 24:385\u2013398","journal-title":"Histol Histopathol"},{"key":"9750_CR59","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ncb0901-793","volume":"3","author":"A Ryo","year":"2001","unstructured":"Ryo A, Nakamura M, Wulf G et al (2001) Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 3:793\u2013801","journal-title":"Nat Cell Biol"},{"key":"9750_CR60","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1158\/0008-5472.CAN-06-0100","volume":"66","author":"M Dolled-Filhart","year":"2006","unstructured":"Dolled-Filhart M, McCabe A, Giltnane J et al (2006) Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 66:5487\u20135494","journal-title":"Cancer Res"},{"key":"9750_CR61","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.bjc.6600624","volume":"87","author":"SC Wong","year":"2002","unstructured":"Wong SC, Lo SF, Lee KC et al (2002) Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. Br J Cancer 87:1281\u20131286","journal-title":"Br J Cancer"},{"key":"9750_CR62","doi-asserted-by":"crossref","first-page":"42575","DOI":"10.1074\/jbc.M111.294595","volume":"286","author":"Y Chen","year":"2011","unstructured":"Chen Y, Shi HY, Stock SR et al (2011) Regulation of breast cancer-induced bone lesions by \u03b2-catenin protein signaling. J Biol Chem 286:42575\u201342584","journal-title":"J Biol Chem"},{"key":"9750_CR63","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10585-014-9682-1","volume":"31","author":"RW Johnson","year":"2014","unstructured":"Johnson RW, Merkel AR, Page JM et al (2014) PTHrP Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Clin Exp Metastasis 31:945\u2013959","journal-title":"Clin Exp Metastasis"},{"key":"9750_CR64","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/0008-5472.CAN-10-2993","volume":"71","author":"RW Johnson","year":"2010","unstructured":"Johnson RW, Mai PN, Susan SP et al (2010) TGF-\u03b2 promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical hedgehog signaling. Cancer Res 71:822\u2013831","journal-title":"Cancer Res"},{"key":"9750_CR65","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY et al (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871\u2013890","journal-title":"Cell"},{"key":"9750_CR66","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.molonc.2010.06.005","volume":"4","author":"SP McDermott","year":"2010","unstructured":"McDermott SP, MS Wicha (2010) Targeting breast cancer stem cells. Mol Oncol 4:404\u2013419","journal-title":"Mol Oncol"},{"key":"9750_CR67","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Mai-Jing L et al (2008) The epithelial-mesenchymal transition generates cells wit properties of stem cells. Cell 133:704\u2013715","journal-title":"Cell"},{"key":"9750_CR68","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.cell.2011.04.029","volume":"145","author":"C Scheel","year":"2011","unstructured":"Scheel C, Eaton EN, Li SH et al (2011) Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145:926\u2013940","journal-title":"Cell"},{"issue":"7","key":"9750_CR69","doi-asserted-by":"crossref","first-page":"e67811","DOI":"10.1371\/journal.pone.0067811","volume":"8","author":"R Lamb","year":"2013","unstructured":"Lamb R, Ablett MP, Spence K et al (2013) Wnt pathway activity in breast cancer sub-types and stem-like cells. PLoS One 8(7):e67811","journal-title":"PLoS One"},{"key":"9750_CR70","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.bjc.6600624","volume":"87","author":"KB Pedersen","year":"2002","unstructured":"Pedersen KB, Nesland JM, Fodstad O et al (2002) Expression of S100A4. E-cadherin, alpha- and beta-catenin in breast cancer biopsies. Br J Cancer 87:1281\u20131286","journal-title":"Br J Cancer"},{"key":"9750_CR71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/path.831","volume":"193","author":"CE Gillett","year":"2001","unstructured":"Gillett CE, Miles DW, Ryder K et al (2001) Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. J Pathol 193:433\u2013441","journal-title":"J Pathol"},{"key":"9750_CR72","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y","volume":"185","author":"IK Bukholm","year":"1998","unstructured":"Bukholm IK, Nesland JM, Karesen R et al (1998) E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 185:262\u2013266","journal-title":"J Pathol"},{"key":"9750_CR73","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0960-9822(01)00360-8","volume":"11","author":"AM Zorn","year":"2001","unstructured":"Zorn AM (2001) Wnt signalling: antagonistic Dickkopfs. Curr Biol 11:592\u2013595","journal-title":"Curr Biol"},{"key":"9750_CR74","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/34848","volume":"391","author":"A Glinka","year":"1998","unstructured":"Glinka A, Wu W, Delius H et al (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391:357\u2013362","journal-title":"Nature"},{"key":"9750_CR75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/35077108","volume":"411","author":"J Mao","year":"2001","unstructured":"Mao J, Wu W, Li Y et al (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411:321\u2013325","journal-title":"Nature"},{"key":"9750_CR76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0378-1119(02)01106-X","volume":"302","author":"B Mao","year":"2003","unstructured":"Mao B, Niehrs C (2003) Kremen2 modulates Dickkopf2 activity during Wnt\/LRP6 signalling. Gene 302:179\u2013183","journal-title":"Gene"},{"key":"9750_CR77","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature756","volume":"417","author":"B Mao","year":"2002","unstructured":"Mao B, Wu W, Davidson G et al (2002) Kremen proteins are Dickkopf receptors that regulate Wnt\/\u03b2-catenin signalling. Nature 417:664\u2013667","journal-title":"Nature"},{"key":"9750_CR78","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0960-9822(00)00868-X","volume":"10","author":"W Wu","year":"2000","unstructured":"Wu W, Glinka A, Delius H et al (2000) Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt\/\u03b2-catenin signalling. Curr Biol 10:1611\u20131614","journal-title":"Curr Biol"},{"key":"9750_CR79","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1128\/MCB.22.17.6100-6110.2002","volume":"22","author":"BK Brott","year":"2002","unstructured":"Brott BK, Sokol SY (2002) Regulation of Wnt\/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol 22:6100\u20136110","journal-title":"Mol Cell Biol"},{"key":"9750_CR80","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden LM, Mao J, Belsky J et al (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513\u20131521","journal-title":"N Engl J Med"},{"key":"9750_CR81","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","volume":"107","author":"Y Gong","year":"2001","unstructured":"Gong Y, Slee RB, Fukai N et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513\u2013523","journal-title":"Cell"},{"key":"9750_CR82","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","volume":"21","author":"F Morvan","year":"2006","unstructured":"Morvan F, Boulukos K, Clement-Lacroix P et al (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21:934\u2013945","journal-title":"J Bone Miner Res"},{"key":"9750_CR83","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","volume":"39","author":"J Li","year":"2006","unstructured":"Li J, Sarosi I, Cattley RC et al (2006) Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39:754\u2013766","journal-title":"Bone"},{"key":"9750_CR84","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1136\/ard.2010.132852","volume":"69","author":"GR Heiland","year":"2010","unstructured":"Heiland GR, Zwerinal K, Baum W et al (2010) Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis 69:2152\u20132159","journal-title":"Ann Rheum Dis"},{"key":"9750_CR85","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/art.27357","volume":"62","author":"LH Weng","year":"2010","unstructured":"Weng LH, Wang CJ, Ko JY et al (2010) Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees. Arthritis Rheum 62:1393\u20131402","journal-title":"Arthritis Rheum"},{"key":"9750_CR86","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00125-006-0144-4","volume":"49","author":"C Christodoulides","year":"2006","unstructured":"Christodoulides C, Scarda A, Granzotto M et al (2006) WNT10B mutations in human obesity. Diabetologia 49:678\u2013684","journal-title":"Diabetologia"},{"key":"9750_CR87","doi-asserted-by":"crossref","first-page":"20505","DOI":"10.1074\/jbc.M800851200","volume":"283","author":"SL Cheng","year":"2008","unstructured":"Cheng SL, Shao JS, Cai J et al (2008) Msx2 exerts bone anabolism via canonical Wnt signaling. J Biol Chem 283:20505\u201320522","journal-title":"J Biol Chem"},{"key":"9750_CR88","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156\u2013163","journal-title":"Nat Med"},{"key":"9750_CR89","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s13277-013-1411-x","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu Y, Tang W, Xie L et al (2014) Prognostic significance of dickkopf-1 overexpression in solid tumors: a meta-analysis. Tumour Biol 35:3145\u20133154","journal-title":"Tumour Biol"},{"key":"9750_CR90","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/aps.2009.200","volume":"31","author":"XL Zhou","year":"2010","unstructured":"Zhou XL, Qin XR, Zhang XD et al (2010) Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt\/beta-catenin signaling. Acta Pharmacol Sin 31:202\u2013210","journal-title":"Acta Pharmacol Sin"},{"key":"9750_CR91","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.14-253997","volume":"29","author":"HY Kim","year":"2015","unstructured":"Kim HY, Park JH, Won HY et al (2015) CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt\/\u03b2-catenin pathway. FASEB J 29:300\u2013313","journal-title":"FASEB J"},{"key":"9750_CR92","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-007-9867-2","volume":"112","author":"AM Mikheey","year":"2008","unstructured":"Mikheey AM, Mikheeva SA, Maxwell JP et al (2008) Dickkopf-1 mediated tumor suppression in human breast carcinoma cells. Breast Cancer Res Treat 112:263\u2013273","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"9750_CR93","doi-asserted-by":"crossref","first-page":"e24225","DOI":"10.1371\/journal.pone.0024225","volume":"6","author":"Z Agur","year":"2011","unstructured":"Agur Z, Kirnasovsky OU, Vasserman G et al (2011) Dickkopf1 regulates fate decision and drives breast cancer stem cells to differentiation: an experimentally supported mathematical model. PLoS One 6(9):e24225","journal-title":"PLoS One"},{"key":"9750_CR94","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1158\/0008-5472.CAN-09-3879","volume":"70","author":"N Sato","year":"2010","unstructured":"Sato N, Yamabuki T, Takano A et al (2010) Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res 70:5326\u20135336","journal-title":"Cancer Res"},{"key":"9750_CR95","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.bjc.6603579","volume":"96","author":"MA Forget","year":"2007","unstructured":"Forget MA, Turcotte S, Beauseigle D et al (2007) The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer 96:646\u2013653","journal-title":"Br J Cancer"},{"key":"9750_CR96","author":"WH Xu","year":"2012","unstructured":"Xu WH, Liu ZB, Yang C et al (2012) Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype. PLoS One. doi: 10.1371\/journal.pone.0037624","journal-title":"PLoS One"},{"key":"9750_CR97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13000-014-0161-4","volume":"9","author":"SJ Zhou","year":"2014","unstructured":"Zhou SJ, Zhou SR, Yang XQ et al (2014) Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer. Diagn Pathol 9:161","journal-title":"Diagn Pathol"},{"key":"9750_CR98","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","volume":"7","author":"T Hideshima","year":"2007","unstructured":"Hideshima T, Mitsiades C, Tonon G et al (2007) Understanding multiple myloma pathogenesis in the bone marrow to identify new therapeutics targets. Nat Rev Cancer 7:585\u2013595","journal-title":"Nat Rev Cancer"},{"key":"9750_CR99","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2008-01-132134","volume":"112","author":"YW Qiang","year":"2008","unstructured":"Qiang YW, Chen Y, Stephens O et al (2008) Myeloma derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. Blood 112:196\u2013207","journal-title":"Blood"},{"key":"9750_CR100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00223-009-9225-y","volume":"84","author":"N Voorzanger-Rousselot","year":"2009","unstructured":"Voorzanger-Rousselot N, Journe F, Doriath V et al (2009) Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases. Calcif Tissue Int 84:348\u2013354","journal-title":"Calcif Tissue Int"},{"key":"9750_CR101","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1359\/jbmr.2001.16.8.1486","volume":"16","author":"T Yoneda","year":"2001","unstructured":"Yoneda T, Williams PJ, Hiraga T et al (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16:1486\u20131495","journal-title":"J Bone Miner Res"},{"key":"9750_CR102","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.bjc.6603959","volume":"97","author":"N Voorzanger-Rousselot","year":"2007","unstructured":"Voorzanger-Rousselot N, Goehrig D, Journe F et al (2007) Increased Dickkopf-1 expression in breast cancer bone metastases. Br J Cancer 97:964\u2013970","journal-title":"Br J Cancer"},{"key":"9750_CR103","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ijc.23625","volume":"123","author":"G Bu","year":"2008","unstructured":"Bu G, Lu W, Liu CC et al (2008) Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases. Int J Cancer 123:1034\u20131042","journal-title":"Int J Cancer"},{"key":"9750_CR104","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1038\/sj.onc.1207892","volume":"23","author":"A Niida","year":"2004","unstructured":"Niida A, Hiroko T, Kasai M et al (2004) DKK1, a negative regulator of Wnt signaling, is a target of the \u03b2-catenin\/TCF pathway. Oncogene 23:8520\u20138526","journal-title":"Oncogene"},{"key":"9750_CR105","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/ijc.26449","volume":"130","author":"ME Menezes","year":"2012","unstructured":"Menezes ME, Devine DJ, Shevde LA et al (2012) Dickkopf1: a tumor suppressor or metastasis promoter? Int J Cancer 130:1477\u20131483","journal-title":"Int J Cancer"},{"key":"9750_CR106","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1359\/jbmr.060810","volume":"21","author":"DL Ellies","year":"2006","unstructured":"Ellies DL, Viviano B, McCarthy J et al (2006) Bone density ligand. Sclerostin directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. Bone Miner 21:1738\u20131749","journal-title":"Bone Miner"},{"key":"9750_CR107","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3299","volume":"10","author":"M Kawai","year":"2011","unstructured":"Kawai M, M\u00f6dder UI, Khosia S et al (2011) Emerging therapeutic opportunities for skeletal restoration. Nat Rev Drug Discov 10:141\u2013156","journal-title":"Nat Rev Drug Discov"},{"key":"9750_CR108","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/bcr3048","volume":"13","author":"D Mendoza-Villanueva","year":"2011","unstructured":"Mendoza-Villanueva D, Zeef L, Shore P (2011) Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2-CBF\u03b2-dependent expression of the Wnt antagonist, sclerostin. Breast Cancer Res 13:R106","journal-title":"Breast Cancer Res"},{"key":"9750_CR109","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","volume":"6","author":"DL Bezooijen van","year":"2004","unstructured":"van Bezooijen DL, Roelen BAJ, Visser A et al (2004) Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 6:805\u2013814","journal-title":"J Exp Med"},{"key":"9750_CR110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pharmthera.2012.02.005","volume":"134","author":"TD Rachner","year":"2012","unstructured":"Rachner TD, Hadji P, Hofbauer LC (2012) Novel therapies in benign and malignant bone diseases. Pharmacol Ther 134:338\u2013344","journal-title":"Pharmacol Ther"},{"key":"9750_CR111","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","volume":"113","author":"JJ Pinzone","year":"2009","unstructured":"Pinzone JJ, Hall BM, Thudi NK et al (2009) The role of Dikkopf-1 in bone development, homeostasis, and disease. Blood 113:517\u2013525","journal-title":"Blood"},{"key":"9750_CR112","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2014.01.010","volume":"346","author":"TD Rachner","year":"2014","unstructured":"Rachner TD, G\u00f6bel A, Benad-Mehner P et al (2014) Dickkopf-1 as a mediator and novel target in malignant bone disease. Cancer Lett 346:172\u2013177","journal-title":"Cancer Lett"},{"key":"9750_CR113","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bjh.13056","volume":"167","author":"SP Iyer","year":"2014","unstructured":"Iyer SP, Beck JT, Ak Stewart et al (2014) A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events. Br J Haematol 167:366\u2013375","journal-title":"Br J Haematol"},{"key":"9750_CR114","author":"TD Rachner","year":"2014","unstructured":"Rachner TD, G\u00f6bel A, Thiele S (2014) Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. Breast Cancer Res. doi: 10.1186\/bcr3616","journal-title":"Breast Cancer Res"},{"key":"9750_CR115","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00432-014-1726-z","volume":"140","author":"I Kyvernitakis","year":"2014","unstructured":"Kyvernitakis I, Rachner TD, Urbschat A et al (2014) Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer. J Cancer Res Clin Oncol 140:1671\u20131680","journal-title":"J Cancer Res Clin Oncol"},{"key":"9750_CR116","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1158\/1078-0432.CCR-08-1572","volume":"14","author":"RE Coleman","year":"2008","unstructured":"Coleman RE, Guise TA, Lipton A et al (2008) Advancing treatment for metastatic bone cancer: consensus recommendations from the second Cambridge Conference. Clin Cancer Res 14:6387\u20136395","journal-title":"Clin Cancer Res"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-015-9750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-015-9750-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-015-9750-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T11:51:40Z","timestamp":1653220300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-015-9750-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":116,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9750"],"URL":"https:\/\/doi.org\/10.1007\/s10585-015-9750-1","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]}}}